rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Trupanion, Inc.

TRUP · Nasdaq

Health CareManaged Care & InsurersAbove a falling average

TRUP stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 9.9% above that average now. Managed Care & Insurers: 70% of its 10 stocks in an uptrend (±0 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 52
Industry in uptrend
70% 0 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$4.3M
Officials’ trades on record
19
Institutions holding
183 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
13%50%87%Apr 26Jun 26Jul 26Sep 26Oct 26

Managed Care & Insurers: Most of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$2.9M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

19 disclosed lines: House 15, Senate 0, executive 4; 3 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k4 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k30 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k26 Feb 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k26 Jan 2026filed 14 May 2026
Bradley Scott Schneider House: U.S. House ClerkIL10soldjoint$50k–$100k10 Dec 2021filed 17 Mar 2022
Bradley Scott Schneider House: U.S. House ClerkIL10exchangedjoint$50k–$100k10 Dec 2021filed 17 Mar 2022
Bradley Scott Schneider House: U.S. House ClerkIL10soldspouse$15k–$50k7 Dec 2021filed 13 Aug 2022
Marie Newman House: U.S. House ClerkIL03soldjoint$1k–$15k16 Jul 2021filed 5 Aug 2021
Marie Newman House: U.S. House ClerkIL03soldjoint$1k–$15k21 May 2021filed 10 Jun 2021
Marie Newman House: U.S. House ClerkIL03bought$1k–$15k22 Mar 2021filed 15 Apr 2021
Marie Newman House: U.S. House ClerkIL03boughtjoint$1k–$15k16 Feb 2021filed 15 Apr 2021
Bradley Scott Schneider House: U.S. House ClerkIL10soldspouse$50k–$100k8 Feb 2021filed 13 Aug 2022

Insiders

Buy orders, 12 months0
Sale orders, 12 months27
Buyers · sellers0 · 5
WhoDidSharesTraded
Margaret ToothCEOsold1,000at $25.849 Oct 2026filed 13 Oct 2026
John R. GallagherChief Operating Officersold431at $22.9228 Sep 2026filed 30 Sep 2026
Margaret ToothCEOsold1,000at $25.0011 Sep 2026filed 15 Sep 2026
John R. GallagherChief Operating Officersold3,604at $29.7028 Aug 2026filed 1 Sep 2026
Fawwad QureshiChief Financial Officersold6,111at $30.0126 Aug 2026filed 26 Aug 2026
Margaret ToothCEOsold491at $31.8425 Aug 2026filed 26 Aug 2026
Margaret ToothCEOsold978at $29.0511 Aug 2026filed 13 Aug 2026
John R. GallagherChief Operating Officersold431at $25.0828 Jul 2026filed 30 Jul 2026
John R. GallagherChief Operating Officersold431at $25.3529 Jun 2026filed 1 Jul 2026
Steve WeinrauchEVP, North Am & Vet Strategysold6,674at $22.005 Jun 2026filed 9 Jun 2026
John R. GallagherChief Operating Officersold3,603at $21.6928 May 2026filed 1 Jun 2026
Fawwad QureshiChief Financial Officersold6,007at $22.1727 May 2026filed 27 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders183-3 on the quarter
New · exited34 · 36
Reported value$831.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.reduced · filed 7 Aug 20265,441,008$134.8M-2,1120.0%
Capital World Investorsadded · filed 12 Aug 20263,840,269$95.1M+58,630+1.6%
Aflac Incunchanged · filed 7 Aug 20263,636,364$90.1M00.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20261,801,498$44.6M+38,921+2.2%
Polar Capital Holdings Plcadded · filed 14 Aug 20261,750,000$43.3M+125,000+7.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,486,377$36.8M+33,221+2.3%
STATE STREET CORPadded · filed 7 Aug 20261,365,662$33.8M+48,219+3.7%
FMR LLCreduced · filed 13 Aug 20261,040,565$25.8M-314,001−23.2%
MORGAN STANLEYadded · filed 13 Aug 2026901,215$22.3M+203,343+29.1%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026875,839$21.7M-2,231−0.3%
31 Mar 2023 – 30 Jun 2026
161188215Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Margaret Tooth Company insiderCEO · last 9 Oct 20260 · 74
John R. Gallagher Company insiderChief Operating Officer · last 28 Sep 20260 · 13
Fawwad Qureshi Company insiderChief Financial Officer · last 26 Aug 20260 · 14
Asher Bearman Company insiderChief Legal Officer · last 25 Aug 20260 · 35
Bradley S. Powell Company insiderDirector · last 25 Aug 20260 · 0
Brenna McGibney Company insiderChief Administration Officer · last 25 Aug 20260 · 3
Simon Wheeler Company insiderEVP, Trupanion International · last 25 Aug 20260 · 0
Steve Weinrauch Company insiderEVP, North Am & Vet Strategy · last 25 Aug 20260 · 5
Darryl Rawlings Company insiderDirector · last 22 Aug 20262 · 175
Howard E. Rubin Company insiderDirector · last 22 Aug 20260 · 33
Donald J. Trump Executive branchWhite House Office · last 4 Jun 20262 · 2
Elizabeth McLaughlin Company insiderDirector · last 11 May 20260 · 0

Same industry

HUM HumanaLeading+25%
CNC CenteneLeading+19%
MOH Molina HealthcareJust started moving+9%
UNH UnitedHealth GroupJust started moving+6%
CI The Cigna GroupAbove a falling average+8%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202516.1%
Operating profit marginFY 2025 · to 31 Dec 20251.0%
Free cash flow marginFY 2025 · to 31 Dec 20255.2%
Return on capital employedFY 2025 · to 31 Dec 20252.7%
Debt to equityFY 2025 · to 31 Dec 20250.29×
Interest coverFY 2025 · to 31 Dec 20251.01×
Share count trendFY 2025 · to 6 Feb 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$138.0M
Free cash flowFY 2025 · to 31 Dec 2025$75.4M

Analyst forecasts

No analyst forecasts yet.